These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Multimodality approaches for rectal cancer. Yang G; Wagner TD; Thomas CR Curr Probl Cancer; 2004; 28(6):316-42. PubMed ID: 15570567 [No Abstract] [Full Text] [Related]
8. Comparison of volumetric-modulated arc therapy using simultaneous integrated boosts (SIB-VMAT) of 45 Gy/55 Gy in 25 fractions with conventional radiotherapy in preoperative chemoradiation for rectal cancers: a propensity score case-matched analysis. Yamashita H; Ishihara S; Nozawa H; Kawai K; Kiyomatsu T; Okuma K; Abe O; Watanabe T; Nakagawa K Radiat Oncol; 2017 Sep; 12(1):156. PubMed ID: 28934968 [TBL] [Abstract][Full Text] [Related]
9. [Developments up to now and current status of adjuvant chemo- and radiotherapy in colonic and rectal carcinoma]. Kraus TW; Eble MJ; Raeth U Langenbecks Arch Chir; 1994; 379(6):353-7. PubMed ID: 7845161 [TBL] [Abstract][Full Text] [Related]
10. A prospective pilot study of target-guided personalized chemotherapy with intensity-modulated radiotherapy in patients with early rectal cancer. Cubillo A; Hernando-Requejo O; García-García E; Rodriguez-Pascual J; De Vicente E; Morelli P; Rubio C; López-Ríos F; Muro A; López U; Prados S; Quijano Y; Hidalgo M Am J Clin Oncol; 2014 Apr; 37(2):117-21. PubMed ID: 23211222 [TBL] [Abstract][Full Text] [Related]
11. Chemoradiotherapy for rectal cancer: current status and perspectives. Watanabe T; Kiyomatsu T; Kanazawa T; Tada T; Komuro Y; Tsurita G; Muto T; Nagawa H Int J Clin Oncol; 2004 Dec; 9(6):475-83. PubMed ID: 15616878 [No Abstract] [Full Text] [Related]
12. Integration of novel agents into combined-modality treatment for rectal cancer patients. Rödel C; Sauer R Strahlenther Onkol; 2007 May; 183(5):227-35. PubMed ID: 17497093 [TBL] [Abstract][Full Text] [Related]
13. Advances in radiotherapy and targeted therapies for rectal cancer. Sermeus A; Leonard W; Engels B; De Ridder M World J Gastroenterol; 2014 Jan; 20(1):1-5. PubMed ID: 24415852 [TBL] [Abstract][Full Text] [Related]
15. Preoperative sequential short-term radiotherapy plus chemotherapy can induce complete remission in T3N2 rectal cancer. Widder J; Herbst F; Scheithauer W Acta Oncol; 2005; 44(8):921-3. PubMed ID: 16332603 [No Abstract] [Full Text] [Related]
16. Developments in the use of chemoradiotherapy in rectal cancer. Sebag-Montefiore D Colorectal Dis; 2006 Sep; 8 Suppl 3():14-7. PubMed ID: 16813586 [TBL] [Abstract][Full Text] [Related]
17. [Adjuvant treatment in rectal cancer]. Lise M; Nitti D; Chemello F; Zane D; Taboga L; De Carli GL; Bachi V; Civalleri D; Bonalumi U Ann Ital Chir; 1992; 63(3):321-32. PubMed ID: 1443998 [No Abstract] [Full Text] [Related]
18. [Established data and practical recommendations concerning pre- and postoperative chemotherapy of rectal cancer]. Rougier P; Mitry E; Clavéro-Fabri MC; Penna C; Nordlinger B Ann Chir; 1999; 53(10):1011-8. PubMed ID: 10670150 [TBL] [Abstract][Full Text] [Related]
19. Combined-modality therapy for rectal cancer using irinotecan. Minsky BD Oncology (Williston Park); 2002 May; 16(5 Suppl 5):35-8. PubMed ID: 12109805 [TBL] [Abstract][Full Text] [Related]
20. Preoperative or postoperative therapy for stage II or III rectal cancer: an updated practice guideline. Wong RK; Berry S; Spithoff K; Simunovic M; Chan K; Agboola O; Dingle B; Clin Oncol (R Coll Radiol); 2010 May; 22(4):265-71. PubMed ID: 20398849 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]